Rein Therapeutics Statistics
Total Valuation
RNTX has a market cap or net worth of $30.65 million. The enterprise value is -$4.84 million.
Important Dates
The last earnings date was Monday, November 16, 2026, before market open.
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
RNTX has 86.27 million shares outstanding. The number of shares has increased by 128.93% in one year.
| Current Share Class | 86.27M |
| Shares Outstanding | 86.27M |
| Shares Change (YoY) | +128.93% |
| Shares Change (QoQ) | +2.98% |
| Owned by Insiders (%) | 6.02% |
| Owned by Institutions (%) | 36.25% |
| Float | 65.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.95 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.57, with zero debt.
| Current Ratio | 6.57 |
| Quick Ratio | 6.34 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -100.48% and return on invested capital (ROIC) is -28.12%.
| Return on Equity (ROE) | -100.48% |
| Return on Assets (ROA) | -24.60% |
| Return on Invested Capital (ROIC) | -28.12% |
| Return on Capital Employed (ROCE) | -41.36% |
| Weighted Average Cost of Capital (WACC) | 12.17% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$4.97M |
| Employee Count | 10 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -712,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -70.88% in the last 52 weeks. The beta is 1.44, so RNTX's price volatility has been higher than the market average.
| Beta (5Y) | 1.44 |
| 52-Week Price Change | -70.88% |
| 50-Day Moving Average | 0.68 |
| 200-Day Moving Average | 0.99 |
| Relative Strength Index (RSI) | 24.47 |
| Average Volume (20 Days) | 885,180 |
Short Selling Information
The latest short interest is 706,730, so 0.82% of the outstanding shares have been sold short.
| Short Interest | 706,730 |
| Short Previous Month | 590,758 |
| Short % of Shares Out | 0.82% |
| Short % of Float | 1.08% |
| Short Ratio (days to cover) | 1.57 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -22.26M |
| Pretax Income | -50.43M |
| Net Income | -49.72M |
| EBITDA | -22.26M |
| EBIT | -22.26M |
| Earnings Per Share (EPS) | -$0.93 |
Full Income Statement Balance Sheet
The company has $35.49 million in cash and no debt, with a net cash position of $35.49 million or $0.41 per share.
| Cash & Cash Equivalents | 35.49M |
| Total Debt | n/a |
| Net Cash | 35.49M |
| Net Cash Per Share | $0.41 |
| Equity (Book Value) | 52.77M |
| Book Value Per Share | 0.09 |
| Working Capital | 31.19M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -22.55M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 750 |
| Net Borrowing | -1.08M |
| Free Cash Flow | -22.55M |
| FCF Per Share | -$0.26 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
RNTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -128.93% |
| Shareholder Yield | -128.93% |
| Earnings Yield | -261.02% |
| FCF Yield | -73.58% |
Analyst Forecast
The average price target for RNTX is $6.00, which is 1,588.71% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.00 |
| Price Target Difference | 1,588.71% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on November 11, 2022. It was a reverse split with a ratio of 1:20.
| Last Split Date | Nov 11, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |